Clinician-guided interpretation pageThis topic can involve test or imaging interpretation, neurological, cardiac, blood, liver, kidney, lung, surgical, medication, or complex underlying-disease context. BioConst keeps this page as an explainer, not a decision guide.
What this means
Fatty liver disease means fat is present in the liver and is interpreted with metabolic and fibrosis context.[1,2]
What people may notice
- NAFLD is also referred to as MASLD in NIDDK patient material.[1,2]
- Blood tests, imaging, and sometimes biopsy may enter diagnosis and staging context.[1,2]
Why it happens
- Metabolic factors such as obesity, insulin resistance, diabetes, triglycerides, and metabolic syndrome can increase risk.[1,2]
- Other causes of liver fat and alcohol-associated liver disease need clinical separation.[1,2]
Clinical response directions
- Clinical teams may use history, exam, labs, imaging, and specialist review depending on fatty liver context.[1,2]
- BioConst explains the map and does not diagnose, rank urgency, choose tests, or recommend treatment.[1,2]
Common traps
- Fat on imaging does not automatically identify inflammation.[1,2]
- Normal enzymes do not automatically exclude clinically important disease.[1,2]
- Fatty liver is not a supplement target or a one-number problem.[1,2]